Swapnil Jatinbhai Shah
Fortune : 69 M $ au 31/05/2026
Fortune : 69 M $ au 31/05/2026
Swapnil Jatinbhai Shah is Non-Executive Chairman at Remus Pharmaceuticals Ltd. since 2015.
Holds the position of Managing Director & Executive Director at Senores Pharmaceuticals Ltd. since 2021.
Serves as Director at Ratnagene Lifescience Pvt Ltd., Relius Lifesciences Pvt Ltd., Ratnatris Pharmaceuticals Pvt Ltd., Calypso Hospitality LLP, Sumer Enterprises LLP, Renosen Pharmaceuticals Pvt Ltd., Espee Therapeutics LLP, Aelius Projects LLP, Havix Group, Inc., and Senores Pharmaceuticals, Inc. Education includes an MBA from Hofstra University and undergraduate degrees from Gujarat University and Nirma University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 28/03/2026 | 5 848 031 ( 12,7 % ) | 69 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| REMUS PHARMACEUTICALS LIMITED | Président | 21/09/2015 |
| SENORES PHARMACEUTICALS LIMITED | Directeur Général | 15/10/2021 |
Relius Lifesciences Pvt Ltd. | Directeur/Membre du Conseil | - |
Renosen Pharmaceuticals Pvt Ltd. | Directeur/Membre du Conseil | - |
Ratnatris Pharmaceuticals Pvt Ltd.
Ratnatris Pharmaceuticals Pvt Ltd. Ratnatris Pharmaceuticals Pvt Ltd. is a pharmaceutical company specializing in the development, manufacturing, and supply of affordable, high-quality generic medicines and innovative formulations. Ratnatris operates seven advanced manufacturing facilities, including a US FDA-approved plant in the USA, and produces oral solids, parenterals, beta lactams, and cephalosporins. The company is based in Ahmedabad, India. The Indian company offers a broad portfolio of over 500 commercial products across multiple therapeutic categories, including anaesthetics, anti-infectives, cardiovascular, central nervous system, and nutritional supplements. The company focuses on continuous innovation, developing complex generics supported by robust R&D, clinical trials, regulatory compliance, and intellectual property expertise. Ratnatris maintains stringent quality standards aligned with WHO cGMP and ISO 9001:2008, and holds certifications from various national health authorities. | Directeur/Membre du Conseil | - |
Ratnagene Lifescience Pvt Ltd. | Directeur/Membre du Conseil | - |
Espee Therapeutics LLP | Directeur/Membre du Conseil | - |
Aelius Projects LLP | Directeur/Membre du Conseil | - |
Calypso Hospitality LLP | Directeur/Membre du Conseil | - |
| ░░░░░ ░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 15 |
|---|---|
Hofstra University
Hofstra University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gujarat University
Gujarat University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nirma University
Nirma University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Havix Group, Inc.
Havix Group, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
Senores Pharmaceuticals Pvt Ltd.
Senores Pharmaceuticals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical and generic medicines | Health Technology |
Remus Pharmaceuticals Ltd.
Remus Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products with expertise in neurology, cardiology & gastroenterology | Health Technology |
Senores Pharmaceuticals, Inc.
Senores Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceuticals | Health Technology |
Ratnagene Lifescience Pvt Ltd. | |
Relius Lifesciences Pvt Ltd. | |
Ratnatris Pharmaceuticals Pvt Ltd.
Ratnatris Pharmaceuticals Pvt Ltd. Ratnatris Pharmaceuticals Pvt Ltd. is a pharmaceutical company specializing in the development, manufacturing, and supply of affordable, high-quality generic medicines and innovative formulations. Ratnatris operates seven advanced manufacturing facilities, including a US FDA-approved plant in the USA, and produces oral solids, parenterals, beta lactams, and cephalosporins. The company is based in Ahmedabad, India. The Indian company offers a broad portfolio of over 500 commercial products across multiple therapeutic categories, including anaesthetics, anti-infectives, cardiovascular, central nervous system, and nutritional supplements. The company focuses on continuous innovation, developing complex generics supported by robust R&D, clinical trials, regulatory compliance, and intellectual property expertise. Ratnatris maintains stringent quality standards aligned with WHO cGMP and ISO 9001:2008, and holds certifications from various national health authorities. | |
Calypso Hospitality LLP | |
Sumer Enterprises LLP | |
Renosen Pharmaceuticals Pvt Ltd. | |
Espee Therapeutics LLP | |
Aelius Projects LLP |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national